GVHD Prophylaxis Using PTCY Remains Valid Treatment Option in MDS
Using post-transplant cyclophosphamide (PTCY) for graft-versus-host disease prophylaxis in patients with myelodysplastic syndromes is a valid option compared to antithymocyte ...
Tag: myelodysplastic syndromes
Low-Dose Revlimid May Delay Time to Blood Transfusion Dependency in MDS
Certain patients with MDS receiving Revlimid demonstrated a manageable safety profile. Patients with non-transfusion dependent myelodysplastic syndromes (MDS) who were ...
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia
Patients with lower-risk MDS and anemia may benefit from Reblozyl as standard of care. Image generated by Adobe Firefly.Reblozyl (luspatercept) ...
In a World of Rushing, Cancer Taught Me to Slow Down
As a child and now an adult I remember an oft-repeated quote, “The only constant is change.” The older I ...
My Worries About Being Old as an MDS Survivor
I am amazed at people who are warriors of cancer and still worry about being old. I have a friend ...
‘Tempo’ of MDS Helps With Timing for Stem Cell Transplants
During the treatment process for patients with myelodysplastic syndromes (MDS), the time in which patients receive stem cell transplants matters, ...
Some With MDS May Benefit from Delaying Stem Cell Transplants
For patients with MDS who can delay stem cell transplants, it's important they care for their health beforehand. It’s important ...